These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27431859)

  • 1. EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke's cleft cysts.
    Thimsen V; Hölsken A; Buchfelder M; Flitsch J; Fahlbusch R; Stefanits H; Losa M; Jones DT; Buslei R
    Sci Rep; 2016 Jul; 6():29731. PubMed ID: 27431859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TREM-1 expression in craniopharyngioma and Rathke's cleft cyst: its possible implication for controversial pathology.
    Liu Y; Wang CH; Li DL; Zhang SC; Peng YP; Peng JX; Song Y; Qi ST; Pan J
    Oncotarget; 2016 Aug; 7(31):50564-50574. PubMed ID: 27409178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cysts.
    Schweizer L; Capper D; Hölsken A; Fahlbusch R; Flitsch J; Buchfelder M; Herold-Mende C; von Deimling A; Buslei R
    Neuropathol Appl Neurobiol; 2015 Oct; 41(6):733-42. PubMed ID: 25442675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct patterns of primary and motile cilia in Rathke's cleft cysts and craniopharyngioma subtypes.
    Coy S; Du Z; Sheu SH; Woo T; Rodriguez FJ; Kieran MW; Santagata S
    Mod Pathol; 2016 Dec; 29(12):1446-1459. PubMed ID: 27562488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rathke's cleft cysts: differentiation from other cystic lesions in the pituitary fossa by use of single-shot fast spin-echo diffusion-weighted MR imaging.
    Kunii N; Abe T; Kawamo M; Tanioka D; Izumiyama H; Moritani T
    Acta Neurochir (Wien); 2007 Aug; 149(8):759-69; discussion 769. PubMed ID: 17594050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.
    Buslei R; Nolde M; Hofmann B; Meissner S; Eyupoglu IY; Siebzehnrübl F; Hahnen E; Kreutzer J; Fahlbusch R
    Acta Neuropathol; 2005 Jun; 109(6):589-97. PubMed ID: 15891929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative immunohistochemical assessment of craniopharyngioma and related lesions.
    Le BH; Towfighi J; Kapadia SB; Lopes MB
    Endocr Pathol; 2007; 18(1):23-30. PubMed ID: 17652797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas.
    Yoshimoto K; Hatae R; Suzuki SO; Hata N; Kuga D; Akagi Y; Amemiya T; Sangatsuda Y; Mukae N; Mizoguchi M; Iwaki T; Iihara K
    Neuropathology; 2018 Feb; 38(1):3-10. PubMed ID: 28840946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from rathke cleft cyst.
    Xin W; Rubin MA; McKeever PE
    Arch Pathol Lab Med; 2002 Oct; 126(10):1174-8. PubMed ID: 12296753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF V600E mutation is a useful marker for differentiating Rathke's cleft cyst with squamous metaplasia from papillary craniopharyngioma.
    Kim JH; Paulus W; Heim S
    J Neurooncol; 2015 May; 123(1):189-91. PubMed ID: 25820214
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative immunohistochemical expression of β-catenin, EGFR, ErbB2, and p63 in adamantinomatous and papillary craniopharyngiomas.
    Esheba GE; Hassan AA
    J Egypt Natl Canc Inst; 2015 Sep; 27(3):139-45. PubMed ID: 26198262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in Craniopharyngioma Subtypes and Surrounding Brain Tissue.
    Thimsen V; John N; Buchfelder M; Flitsch J; Fahlbusch R; Stefanits H; Knosp E; Losa M; Buslei R; Hölsken A
    Sci Rep; 2017 Nov; 7(1):15856. PubMed ID: 29158570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary function after endonasal surgery for nonadenomatous parasellar tumors: Rathke's cleft cysts, craniopharyngiomas, and meningiomas.
    Dusick JR; Fatemi N; Mattozo C; McArthur D; Cohan P; Wang C; Swerdloff RS; Kelly DF
    Surg Neurol; 2008 Nov; 70(5):482-90; discussion 490-1. PubMed ID: 18482750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth.
    Stache C; Hölsken A; Fahlbusch R; Flitsch J; Schlaffer SM; Buchfelder M; Buslei R
    Neuro Oncol; 2014 Jan; 16(2):256-64. PubMed ID: 24305709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma.
    Coy S; Rashid R; Lin JR; Du Z; Donson AM; Hankinson TC; Foreman NK; Manley PE; Kieran MW; Reardon DA; Sorger PK; Santagata S
    Neuro Oncol; 2018 Jul; 20(8):1101-1112. PubMed ID: 29509940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rathke's cleft cysts with significant squamous metaplasia--high risk of postoperative deterioration and close origins to craniopharyngioma.
    Ogawa Y; Watanabe M; Tominaga T
    Acta Neurochir (Wien); 2013 Jun; 155(6):1069-75. PubMed ID: 23371400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late development of craniopharyngioma following surgery for Rathke's cleft cyst.
    Park YS; Ahn JY; Kim DS; Kim TS; Kim SH
    Clin Neuropathol; 2009; 28(3):177-81. PubMed ID: 19537134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach.
    Hofmann BM; Kreutzer J; Saeger W; Buchfelder M; Blümcke I; Fahlbusch R; Buslei R
    Am J Surg Pathol; 2006 Dec; 30(12):1595-603. PubMed ID: 17122517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different keratin profiles in craniopharyngioma subtypes and ameloblastomas.
    Tateyama H; Tada T; Okabe M; Takahashi E; Eimoto T
    Pathol Res Pract; 2001; 197(11):735-42. PubMed ID: 11770017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy.
    Martinez-Gutierrez JC; D'Andrea MR; Cahill DP; Santagata S; Barker FG; Brastianos PK
    Neurosurg Focus; 2016 Dec; 41(6):E2. PubMed ID: 27903124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.